1832 Asset Management’s NeoGenomics NEO Stock Holding History

1832 Asset Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-72,800	Closed	-$2.03M	–	698
2020 Q1	$2.03M	Buy	+72,800	New	+$2.18M	0.01%	414

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

1832 Asset Management's NEO Position: Q2 2020 in Review

1832 Asset Management sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 72,800 shares — an estimated $2.03M sold.

1832 Asset Management first reported a position in NEO in Q1 2020 and held it in 1 quarter. The position peaked at $2.03M in Q1 2020. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.

1832 Asset Management reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
1832 Asset Management sold 72,800 NeoGenomics shares in Q2 2020, an estimated $2.03M.
1832 Asset Management first reported a position in NeoGenomics in Q1 2020 and held it in 1 quarter.
1832 Asset Management's NeoGenomics position peaked at $2.03M in Q1 2020.
285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.

Based on 1832 Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.